Scientific Program

Day 01
28.08.2021
Day 02
29.08.2021

Conference Hall A
Conference Hall B

11:15 AM - 12:15 PM

Point of Care testing in Diabetes

12:30 PM - 01:00 PM

Opening Remarks and Introductions

100 YEARS OF INSULIN

01:00 PM - 01:20 PM

Evolution of Insulin Therapy in India

Chairperson : JK Sharma | Sunil Gupta

01:20 PM - 01:40 PM

Insulin Yesterday, Today and Beyond

Chairperson : JK Sharma | Sunil Gupta

01:40 PM - 02:00 PM

Advances in Insulin Delivery

Chairperson : JK Sharma | Sunil Gupta

02:00 PM - 02:15 PM

Discussion

PLENARY SESSION 1

02:15 PM - 02:45 PM

DIABETES, OBESITY AND COVID-19

Chairperson : Banshi Saboo | Dheeraj Kapoor

DEBATE 1

02:45 PM - 03:30 PM

Do Lifestyle Interventions Still Have A Role in Diabetes Management?

Chairperson : BM Makkar | Girish Khurana

LEARNINGS FROM LANDMARK TRIALS

03:30 PM - 03:45 PM

Surpass Studies

Chairperson : AK Das | SV Madhu

03:45 PM - 04:00 PM

Step Studies

Chairperson : AK Das | SV Madhu

04:00 PM - 04:20 PM

Dare-19

Chairperson : AK Das | SV Madhu

04:20 PM - 04:35 PM

Grade Study

Chairperson : AK Das | SV Madhu

04:35 PM - 04:50 PM

Trials with Dual SGLT Inhibitors

Chairperson : AK Das | SV Madhu

04:50 PM - 05:05 PM

EMPEROR PRESERVED

Chairperson : AK Das | SV Madhu

05:05 PM - 05:30 PM

Discussion

PLENARY SESSION 2

05:30 PM - 06:00 PM

ABCD, DBCD, & CMBCD - Clinical Implications

Chairperson : V Mohan | Sanjay Agarwal

PLENARY SESSION 3

06:00 PM - 06:30 PM

Novel Subgroups of Type 2 Diabetes in India

Chairperson : Chantal Mathieu | Adi Mehta

Emerging Options for Glucose Lowering in T2D

06:30 PM - 06:50 PM

Insulin + SGLT2i

Chairperson : Shalini Jaggi | Mithun Bhartia

06:50 PM - 07:10 PM

Insulin + GLP1RA

Chairperson : Shalini Jaggi | Mithun Bhartia

07:10 PM - 07:20 PM

Discussion

Managing Hyperglycemia in COVID Patients

07:20 PM - 07:40 PM

Nutritional Management

Chairperson : Hemant Thacker | Amit Gupta

07:40 PM - 08:00 PM

Pharmacotherapy

Chairperson : Hemant Thacker | Amit Gupta

08:00 PM - 08:20 PM

Monitoring

Chairperson : Hemant Thacker | Amit Gupta

08:20 PM - 08:40 PM

Long COVID 19 inertia

Chairperson : Hemant Thacker | Amit Gupta

08:40 PM - 09:00 PM

Discussion

ROCHE SYMPOSIUM

11:15 AM - 11:45 AM

Glucovigilance- A key to for the personalised management of diabetes

11:45 AM - 12:15 PM

Clinical and patient benefits of integrated personalised Diabetes management tool

Conference Hall A
Conference Hall B
Conference Hall C

09:30 AM - 10:30 AM

SMBG Workshop - Lifescan

BIOCON SYMPOSIUM

10:30 AM - 10:45 AM

Insulin Initiation and Challenges : A real life example!!!

10:45 AM - 11:00 AM

Clinical Immersions - When & Whom to start insulin in T2DM patients

11:00 AM - 11:15 AM

Clinical Immersions: Optimisation/Titration with Basal Insulin A pragmatic approach

11:15 AM - 11:30 AM

Discussion

NOVO NORDISK SYMPOSIUM

11:30 AM - 11:50 AM

Individualization of insulin therapy: Choosing the right solution for your diverse patients

Chairperson : Abhay Ahluwalia

11:50 AM - 12:10 PM

The Diabetes GAME Changer: Journey of Oral Semaglutide from lab to life

Chairperson : Abhay Ahluwalia

12:10 PM - 12:30 PM

Panel discussion and Q&A

TYPE 1 DIABETES SYMPOSIUM

12:45 PM - 01:05 PM

Managing Type 1 Diabetes - How Has it Evolved

Chairperson : Rakesh Sahay | Meena Chabra

01:05 PM - 01:25 PM

Are We Doing Enough for Type 1 Diabetes?

Chairperson : Rakesh Sahay | Meena Chabra

01:25 PM - 01:45 PM

Minimizing Hypoglycemia in Real World

Chairperson : Rakesh Sahay | Meena Chabra

01:45 PM - 02:00 PM

Discussion

ADVANCES IN CARDIO RENAL RISK MANAGEMENT

02:00 PM - 02:20 PM

Lessons Learnt from Landmark HF Trials

Chairperson : Balbir Singh | Sengupta

02:20 PM - 02:40 PM

Lessons Learnt from Landmark Kidney Trials

Chairperson : Balbir Singh | Sengupta

02:40 PM - 03:00 PM

Mitigating Cardio-Renal Risk Role of Combining GLP1RA and SGLT2i

Chairperson : Balbir Singh | Sengupta

PHARMACOTHERAPY OF TYPE 2 DIABETES

03:00 PM - 03:20 PM

Evolution of Diabetes Management Guidelines

Chairperson : Vijay Panikar | Vipul Gupta

03:20 PM - 03:40 PM

Many Faces of Metformin

Chairperson : Vijay Panikar | Vipul Gupta

03:40 PM - 04:00 PM

Discussion

EMERGING CONCEPTS

04:00 PM - 04:20 PM

Mechanisms of Beta Cell Failure

Chairperson : TBD | Purvi Chawla

04:20 PM - 04:40 PM

Ominous Octet - Role of Metabolic Inflexibility

Chairperson : TBD | Purvi Chawla

04:40 PM - 05:00 PM

Remission of Type 2 Diabetes - New Insights

Chairperson : TBD | Purvi Chawla

05:00 PM - 05:15 PM

Discussion

PLENARY SESSION 4

05:15 PM - 05:45 PM

Optimising Oral Therapy - How far can/should we go on OADs?

Chairperson : Rajeev Chawla | Kirti Soota

FAT AND TYPE 2 DIABETES

05:45 PM - 06:05 PM

Ectopic Fat And Type 2 Diabetes

Chairperson : Anuj Maheshwari | RM Anjana

06:05 PM - 06:25 PM

Type 2 Diabetes and NAFLD - Indian Context

Chairperson : Anuj Maheshwari | RM Anjana

06:25 PM - 06:45 PM

Dyslipidemia Management and Preventing CVD in Type 2 Diabetes

Chairperson : Anuj Maheshwari | RM Anjana

06:45 PM - 07:00 PM

Discussion

PLENARY SESSION 5

07:00 PM - 07:30 PM

Lipotoxicity or Glucotoxicity? Roles of Lipids and Carbohydrates in Insulin Resistance

Chairperson : Jeffrey I. Mechanick | Neeta Deshpande

GLYCEMIC VARIABILITY

07:30 PM - 07:50 PM

Understanding Pathophysiology of GV

Chairperson : Banshi Saboo | Jothydev

07:50 PM - 08:10 PM

Measuring GV in Clinical Practice

Chairperson : Banshi Saboo | Jothydev

08:10 PM - 08:30 PM

Treating Glycemic Variability

Chairperson : Banshi Saboo | Jothydev

08:30 PM - 08:45 PM

Discussion

08:45 PM - 09:00 PM

CLOSING REMARKS & VALEDICTORY

ALOJA SYMPOSIUM - INDOCO

09:30 AM - 09:50 AM

ALOGLIPTIN- Gliptin with CVOT Asian Data

09:50 AM - 10:10 AM

The Latest USFDA Approved Cardio Safe Gliptin- ALOGLIPTIN

10:10 AM - 10:30 AM

Management of Diabetes with CKD- ALOGLIPTIN

ASTRA ZENECA SYMPOSIUM

10:30 AM - 10:50 AM

Management of Diabetic Dyslipidaemia

10:50 AM - 11:10 AM

SGLT2i now from Prevention to Treatment in T2DM

11:10 AM - 11:30 AM

SGLT2i and Cardio Renal Benefits in T2DM

NOVARTIS SYMPOSIUM

11:30 AM - 11:50 AM

Beta cell preservation: The holy grail in Diabetes Management

11:50 AM - 12:10 PM

Diabetic Retinopathy screening:Perspective from an Ophthalmologist

12:10 PM - 12:30 PM

Prevention of Hospitalisation in HFrEF patients with DM

SANOFI SYMPOSIUM

10:30 AM - 10:50 AM

Basal Insulin in T2DM : Re-defining the Insulin Therapy Landscape over Two decades in India

Chairperson : Sanjay Gupta

10:50 AM - 11:10 AM

Basal insulin intensification with prandial insulin a step wise progression towards glycemic control

Chairperson : Sanjay Gupta

11:10 AM - 11:30 AM

Discussion

BI SYMPOSIUM

11:30 AM - 11:50 AM

Simplifying T2DM Management in Current Era: The Right Choice of DPP4-I

11:50 AM - 12:10 PM

Cardio-Renal-Metabolic approach for T2D Management: Role of SGLT2i/DPP4i FDC